FYI for those GPC colleagues interested in managing drug data standards. Please see the announcement from the VA about NDF-RT below and a perspective from Olivier Bodenreider at NLM who manages RXNORM Jim
James R. Campbell MD campb...@unmc.edu<mailto:campb...@unmc.edu> Office: 402-559-7505 Secretary: 402-559-7299 Pager: 402-888-1230 Begin forwarded message: From: Olivier Bodenreider <obodenrei...@mail.nih.gov<mailto:obodenrei...@mail.nih.gov>> Date: July 7, 2016 at 3:22:38 PM CDT To: "Campbell, James R" <campb...@unmc.edu<mailto:campb...@unmc.edu>> Cc: "McClay, James C" <jmcc...@unmc.edu<mailto:jmcc...@unmc.edu>> Subject: Re: Fwd: VHA Plans to Transition NDF-RT to MED-RT Not sure I have much more information, Jim. I know some of the technical details (e.g., the drugs will be identified with RxCUI natively, rather than NUIs). Not quite sure about editorial procedures. Also keep in mind that, for EPC, chemical ingredient, mechanism of action, and physiologic effect, the same information is also available from DailyMed (and provided independently of NDF-RT in RxClass). So, only the indications/contra-indications and VA classes are at stake here. From the perspective of RxClass, we will keep updating what comes from DailyMed as usual. I imagine the NDF-RT information might be frozen for a while (i.e., not updated) during the transition, until we get a hold of the new dataset and digest it. On 07/07/2016 12:25 PM, Campbell, James R wrote: Olivier, Can you put this announcement by the VA in perspective for us? Are they revising their editorial procedures, maintenance support or integration with RXNORM? How will this affect US EHR terminology deployment? Jim James R. Campbell MD campb...@unmc.edu<mailto:campb...@unmc.edu> Office: 402-559-7505 Secretary: 402-559-7299 Pager: 402-888-1230 Begin forwarded message: From: "McClay, James C" <<mailto:jmcc...@unmc.edu>jmcc...@unmc.edu<mailto:jmcc...@unmc.edu>> Date: July 7, 2016 at 8:57:06 AM CDT To: "Research Informatics Group, UNMC" <<mailto:researchinformat...@unmc.edu>researchinformat...@unmc.edu<mailto:researchinformat...@unmc.edu>> Subject: FW: VHA Plans to Transition NDF-RT to MED-RT Will this change by the VA from NDF-RT to MED-RT impact our work? jm James McClay, MD, MS, FACEP Associate Professor, Emergency Medicine Chair, UNMC Biomedical Informatics Program 981150 Nebraska Medical Center Omaha, NE 68198-1150 <mailto:jmcc...@unmc.edu>jmcc...@unmc.edu<mailto:jmcc...@unmc.edu> <http://www.linkedin.com/in/infodoc>www.linkedin.com/in/infodoc<http://www.linkedin.com/in/infodoc> Twitter: @jmcclay 402-559-3587 From: owner-patientc...@lists.hl7.org<mailto:owner-patientc...@lists.hl7.org> [mailto:owner-patientc...@lists.hl7.org] On Behalf Of Robert Hausam Sent: Tuesday, July 05, 2016 12:06 PM To: Ayres, Elaine (NIH/CC/OD) [E] <<mailto:eay...@cc.nih.gov>eay...@cc.nih.gov<mailto:eay...@cc.nih.gov>> Cc: 'HL7 Patient Care' (patientc...@lists.hl7.org<mailto:patientc...@lists.hl7.org>) <patientc...@lists.hl7.org<mailto:patientc...@lists.hl7.org>> Subject: Re: VHA Plans to Transition NDF-RT to MED-RT I think this is a good move. Thanks for sharing it, Elaine. I believe this would provide a really good foundation for US Realm allergy terminology (as well as for medications, of course). It could be used in C-CDA (instead of the current NDF-RT/RxNorm/UNII/SNOMED CT heuristic) and in FHIR (DAF) and elsewhere. Rob On Tue, Jul 5, 2016 at 10:44 AM, Ayres, Elaine (NIH/CC/OD) [E] <<mailto:eay...@cc.nih.gov>eay...@cc.nih.gov<mailto:eay...@cc.nih.gov>> wrote: Announcement of interest to several PC projects: VHA Plans to Transition NDF-RT to MED-RT In the last quarter of 2016 or the first quarter of 2017, the Veterans Health Administration (VHA) plans to cease further publication of National Drug File Reference Terminology (NDF-RT) and begin releasing a new Medication Reference Terminology (MED-RT) instead on the same monthly schedule. NDF-RT is an important component of the Federal Medication Terminologies (FMT) and related collaborations, and it is anticipated that these will continue to be supported through MED-RT. Distribution of MED-RT is anticipated to be through the same channels as its predecessor, in similar XML and other formats. EVS will evaluate the sample XML when it is released to determine if it presents any challenges. We will communicate any changes in the structure or data that we find and offer assistance in migrating at that time. For more information, see the VHA announcement and FMT Web page: <http://evs.nci.nih.gov/ftp1/NDF-RT/Introduction%20to%20MED-RT.pdf>http://evs.nci.nih.gov/ftp1/NDF-RT/Introduction%20to%20MED-RT.pdf <http://www.cancer.gov/research/resources/terminology/fmt>http://www.cancer.gov/research/resources/terminology/fmt Elaine Ayres *********************************************************************************** Manage your subscriptions<http://www.HL7.org/listservice> | View the archives<http://lists.HL7.org/read/?forum=patientcare> | Unsubscribe<http://www.HL7.org/tools/unsubscribe.cfm?email=rrhau...@gmail.com&list=patientcare> | Terms of use<http://www.HL7.org/myhl7/managelistservs.cfm?ref=nav#listrules> -- Robert Hausam, MD +1 (801) 949-1556 <mailto:rrhau...@gmail.com>rrhau...@gmail.com<mailto:rrhau...@gmail.com> *********************************************************************************** Manage your subscriptions<http://www.HL7.org/listservice> | View the archives<http://lists.HL7.org/read/?forum=patientcare> | Unsubscribe<http://www.HL7.org/tools/unsubscribe.cfm?email=jmcc...@unmc.edu&list=patientcare> | Terms of use<http://www.HL7.org/myhl7/managelistservs.cfm?ref=nav#listrules> The information in this e-mail may be privileged and confidential, intended only for the use of the addressee(s) above. Any unauthorized use or disclosure of this information is prohibited. If you have received this e-mail by mistake, please delete it and immediately contact the sender.
_______________________________________________ Gpc-dev mailing list Gpc-dev@listserv.kumc.edu http://listserv.kumc.edu/mailman/listinfo/gpc-dev
